Within 7 days, the Polish regulatory authority inspected Farmak’s production for compliance with the requirements of Good Manufacturing Practice (GMP) of the European Union. As a result, the company received a positive conclusion from inspectors and, accordingly, an extension of existing EU GMP compliance certificates.
Certificates are issued for 3 years. They apply to production sites for manufacturing sterile and non-sterile medicines.
In addition to the planned recertification, the company received European GMP certificates for new sites that were put into operation during 2021-2023. Among them are sections for the production of sterile medicines in ampoules and vials, medicines in the form of drops and sprays, as well as a section for the production of medicines in tablets.
The first EU GMP certificate was received by Farmak in 2005 from the Latvian regulatory authority.
“During the war, it was especially important for us to undergo European inspection. The obtained EU GMP certificates prove that in any conditions our company adheres to the highest international quality standards for the manufacture of medicines. This allows us to continue to expand Farmak’s presence in European and other foreign markets. And also export our products to more than 50 countries of the world,” said Volodymyr Kostiuk, Executive Director of Farmak.
GMP (Good Manufacturing Practice) is part of a quality assurance system that ensures that pharmaceutical products are manufactured according to quality standards in accordance with the marketing authorization and are fit for purpose. GMP principles and rules are mandatory for all EU member states.
Leading Ukrainian pharmaceutical manufacturer Farmak joined the world’s largest conference, the Radiological Society of North America (RSNA) event, which took place November 26-30 in Chicago. The Radiological Society of North America is a non-profit organization and an international society of radiologists, medical physicists, and other medical imaging...
In November, Farmak ChemPRO was launched, a four-month intensive course, during which 12 chemical students from three leading universities in Kyiv will have the opportunity to gain practical skills and work in a laboratory using modern equipment. During the training, students will receive comprehensive support from leading specialists of the pharmaceutical c...
Several years ago, the pharmaceutical company Farmak launched a scholarship program to support Ukrainian youth who strive to develop in the field of pharmacy. In 2023, the eight best students of Taras Shevchenko Kyiv National University, KNUTD, and NUPh received scholarships from Farmak. The selection of scholarship holders was carried out on a competitive b...